InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
docsetc Free
05/16/24 11:49 AM
profile icon
swamp boy Free
05/16/24 10:13 AM
profile icon
Timing101 Free
05/16/24 10:02 AM
profile icon
Doo-man Free
05/15/24 7:07 PM
profile icon
Doo-man Free
05/15/24 7:05 PM
profile icon
Valuator2 PremiumMember
05/14/24 6:35 PM
profile icon
archilles Free
05/14/24 2:39 PM
profile icon
Timing101 Free
05/14/24 2:05 PM
profile icon
DRHUMI Free
05/14/24 1:39 PM
profile icon
archilles Free
05/14/24 1:36 PM
profile icon
2business Free
05/14/24 12:22 PM
profile icon
Its_TradingG Free
05/14/24 10:57 AM
profile icon
docsetc Free
05/14/24 7:52 AM
profile icon
wickw50 Free
05/13/24 6:00 PM
profile icon
docsetc Free
05/13/24 4:24 PM
profile icon
Mutat Free
05/13/24 2:18 PM
profile icon
2business Free
05/13/24 1:41 PM
profile icon
Timing101 Free
05/13/24 1:18 PM
profile icon
2business Free
05/13/24 1:00 PM
profile icon
Timing101 Free
05/13/24 12:32 PM
profile icon
docsetc Free
05/13/24 11:03 AM
profile icon
Catpole PremiumMember
05/13/24 10:45 AM
profile icon
Valuator2 PremiumMember
05/13/24 10:18 AM
profile icon
SeniorApollo Free
05/13/24 10:01 AM
profile icon
Deportes Free
05/12/24 10:05 PM
profile icon
Mutat Free
05/12/24 9:02 PM
profile icon
Timing101 Free
05/12/24 7:07 PM
profile icon
Timing101 Free
05/12/24 7:06 PM
profile icon
Timing101 Free
05/12/24 7:05 PM
profile icon
I-Glow PremiumMember
05/12/24 3:29 PM
profile icon
I-Glow PremiumMember
05/12/24 2:56 PM
profile icon
Valuator2 PremiumMember
05/12/24 2:18 PM
profile icon
Timing101 Free
05/12/24 12:24 PM
profile icon
Deportes Free
05/12/24 12:23 PM
profile icon
Timing101 Free
05/12/24 12:14 PM
profile icon
Deportes Free
05/12/24 11:36 AM
profile icon
Deportes Free
05/12/24 11:30 AM
profile icon
Timing101 Free
05/12/24 11:27 AM
profile icon
Timing101 Free
05/12/24 11:21 AM
profile icon
DOGONE Free
05/12/24 8:20 AM
profile icon
aarlie Free
05/11/24 10:28 PM
profile icon
Deportes Free
05/11/24 10:36 AM
profile icon
Mutat Free
05/11/24 10:26 AM
profile icon
Timing101 Free
05/11/24 9:57 AM
profile icon
hvp Free
05/11/24 8:44 AM

Enzolytics Inc (ENZC) RSS Feed

Followers
1244
Posters
Posts (Today)
1
Posts (Total)
200280
Created
01/07/10
Type
Free
Moderators Homebrew Timing101 archilles SeniorApollo
P


http://enzolytics.com/











Enzolytics is forecasting $100 Billion of earnings (Profit) over 11 years from just the HIV drug they have developed.




Enzolytics has a technology platform will develop Monoclonal Antibodies (mAb) to target over 14 debilitating diseases, all of which offer of "the promise of total viral neutralization and as a result an effective CURE" - Charles Cotropia, CEO













Our Partners





I

Independent Valuation Report Pre Clinical Studies

 

HIV & AIDS INFO

Global HIV & AIDS statistics — 2019 fact sheet

Global HIV statistics

 

  • 24.5 million [21.6 million–25.5 million] people were accessing antiretroviral therapy (end ofJune 2019).
    37.9 million [32.7 million–44.0 million] people globally were living with HIV (end 2018).
    1.7 million [1.4 million–2.3 million] people became newly infected with HIV (end 2018).
    770 000 [570 000–1.1 million] people died from AIDS-related illnesses (end 2018).
    74.9 million [58.3 million–98.1 million] people have become infected with HIV since the start of the epidemic (end 2018).
    32.0 million [23.6 million–43.8 million] people have died from AIDS-related illnesses since the start of the epidemic (end 2018).

 

Investments

 

  • At the end of 2018, US$ 19.0 billion (constant 2016 dollars) was available for the AIDS response in low- and middle-income countries, almost 1 billion less than in 2017.
    • Around 56% of the total resources for HIV in low- and middle-income countries in 2018 were from domestic sources.

    UNAIDS estimates that US$ 26.2 billion (constant 2016 dollars) will be required for the AIDS response in 2020.

___________________________________________________________________________________



Press Release July 20-2021


Enzolytics Announces the Signing of a Letter of Intent with Creative Biolabs, Inc.

for Licensing and Commercialization of anti-HTLV-1 Monoclonal Antibodies

https://www.creative-biolabs.com/

https://finance.yahoo.com/news/enzolytics-announces-signing-letter-intent-113000339.htm

________________________________________



Press release July 21-2021


Enzolytics and Lonza Bioscience Combine Technologies to Fast-track Development and

Production of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibodies produced by Enzolytics


https://www.lonza.com/


https://www.bloomberg.com/press-releases/2021-07-21/enzolytics-and-lonza-bioscience-combine-technologies-to-fast-track-development-and-production-of-anti-hiv-and-anti-sar



_________________________________________



July 22 INTERVIEW


with
 
James Hicks, Charles Cotropia and Gurav Chandra



http://www.youtube.com/watch?v=mdljO9VLgj0




______________________________________________________________

 

     Press release July 29- 2021
 

Enzolytics Reports Its Progress Toward Completion Of Clinical Trials for Its ITV-1 ANTI-HIV Therapeutic and


Securing Use Authorization Under the European Medicines Agency



https://finance.yahoo.com/news/enzolytics-reports-progress-toward-completion-113000008.html


___________________________________________________________________________________





Aug 25 News Release


https://enzolytics.com/company-news/


 

Enzolytics Progress Update

COLLEGE STATION, TX August 25, 2021

Important Excerpt from this news progress update.
>>>>>><<<<<<

"The monoclonal antibodies being produced by Enzolytics against the CoronaVirus target 19 conserved immutable sites on the virus, sites which the Company has now confirmed are conserved sites not only on the initial virus strains but also existing in the Delta and Lambda variants, as well as in the Alpha, Beta and Gamma variants."


______________________________________________________________



MUST READ UPDATE
•••••• October 7th News Release ••••••


https://www.bloomberg.com/press-releases/2021-10-07/enzolytics-inc-and-samsung-biologics-announce-development-and-manufacturing-agreement-for-anti-hiv-and-anti-sars-cov-2


 

Enzolytics Inc. and Samsung Biologics Announce

Development and Manufacturing Agreement for Anti-

HIV and Anti-SARS-CoV-2




Important Excerpt from this news progress update.

>>>>>><<<<<<

 

     "Samsung Biologics (KRX: 207940. K.S.), a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development company committed to commercializing multiple proprietary therapeutics to treat debilitating infectious diseases, announced the signing of a strategic CDMO partnership agreement."
_______



ENZOLYTICS ..Creating rABS (recombinate monoconal antibodies)   https://info.gbiosciences.com/blog/recombinant-antibodies-an-overview


to eat up HIV and COVID..!





Enzolytics Inc.

2000 North Central Expressway

Plano, TX 75074

972-292-9414

Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
ENZC Latest News
  • No Recent News Available for this company!
New Post